Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in PHATHOM PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 55,788 shares of PHAT (PHATHOM PHARMACEUTICALS INC), worth $619,804 as of 2026-Q1. The position was increased (+82.1% shares). PHAT represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$619,804
Current Shares
55,788
Total Value Change
-$339,684
Total Shares Change
-37,366
Other major holders of PHAT: RA CAPITAL MANAGEMENT, L.P.
Increased |
| 55,788 |
+82.1% |
| $619,804 |
| 0.0% |
| $11.05 |
38 |
| 2025-Q4 | New | 30,631 | - | $508,168 | 0.0% | $16.92 | 33 |
| 2025-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $9.74 | 0 |
| 2025-Q1 | Decreased | 99,744 | -15.3% | $625,395 | 0.0% | $6.60 | 0 |
| 2024-Q4 | Increased | 117,803 | +20.2% | $956,561 | 0.0% | $8.00 | 30 |
| 2024-Q3 | Increased | 98,025 | +5.2% | $1.8M | 0.0% | $17.52 | 27 |
| 2024-Q2 | Increased | 93,154 | +622.5% | $959,488 | 0.0% | $10.30 | 40 |